CN116426547A - Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof - Google Patents
Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof Download PDFInfo
- Publication number
- CN116426547A CN116426547A CN202211009302.6A CN202211009302A CN116426547A CN 116426547 A CN116426547 A CN 116426547A CN 202211009302 A CN202211009302 A CN 202211009302A CN 116426547 A CN116426547 A CN 116426547A
- Authority
- CN
- China
- Prior art keywords
- tfdb
- gene
- protein
- enzyme
- ctx3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010043311 2,4-dichlorophenol hydroxylase Proteins 0.000 title claims abstract description 14
- 230000009466 transformation Effects 0.000 title description 2
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 146
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 62
- HFZWRUODUSTPEG-UHFFFAOYSA-N 2,4-dichlorophenol Chemical class OC1=CC=C(Cl)C=C1Cl HFZWRUODUSTPEG-UHFFFAOYSA-N 0.000 claims abstract description 22
- RANCECPPZPIPNO-UHFFFAOYSA-N 2,5-dichlorophenol Chemical compound OC1=CC(Cl)=CC=C1Cl RANCECPPZPIPNO-UHFFFAOYSA-N 0.000 claims abstract description 8
- VGVRPFIJEJYOFN-UHFFFAOYSA-N 2,3,4,6-tetrachlorophenol Chemical class OC1=C(Cl)C=C(Cl)C(Cl)=C1Cl VGVRPFIJEJYOFN-UHFFFAOYSA-N 0.000 claims description 33
- 108010074633 Mixed Function Oxygenases Proteins 0.000 claims description 14
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 10
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 10
- 230000000593 degrading effect Effects 0.000 claims description 9
- -1 chlorophenol compound Chemical class 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 3
- LHJGJYXLEPZJPM-UHFFFAOYSA-N 2,4,5-trichlorophenol Chemical compound OC1=CC(Cl)=C(Cl)C=C1Cl LHJGJYXLEPZJPM-UHFFFAOYSA-N 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 abstract description 78
- 102000004190 Enzymes Human genes 0.000 abstract description 76
- 230000000694 effects Effects 0.000 abstract description 64
- 230000014509 gene expression Effects 0.000 abstract description 27
- 238000002474 experimental method Methods 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 48
- 239000000523 sample Substances 0.000 description 31
- 239000002689 soil Substances 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 23
- 238000006243 chemical reaction Methods 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 18
- 238000002156 mixing Methods 0.000 description 18
- 239000000758 substrate Substances 0.000 description 17
- 239000006228 supernatant Substances 0.000 description 17
- 239000007788 liquid Substances 0.000 description 16
- 239000000499 gel Substances 0.000 description 15
- 230000006870 function Effects 0.000 description 14
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 14
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 238000001962 electrophoresis Methods 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 238000005406 washing Methods 0.000 description 11
- 238000006911 enzymatic reaction Methods 0.000 description 10
- 238000003908 quality control method Methods 0.000 description 10
- 238000012163 sequencing technique Methods 0.000 description 10
- 238000012546 transfer Methods 0.000 description 10
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 230000006698 induction Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- 239000013612 plasmid Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 241000894007 species Species 0.000 description 7
- ISPYQTSUDJAMAB-UHFFFAOYSA-N 2-chlorophenol Chemical compound OC1=CC=CC=C1Cl ISPYQTSUDJAMAB-UHFFFAOYSA-N 0.000 description 6
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- 240000003793 Rhizophora mangle Species 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 150000001413 amino acids Chemical group 0.000 description 6
- 238000001952 enzyme assay Methods 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 238000000746 purification Methods 0.000 description 6
- 238000005070 sampling Methods 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- 101150036849 tfdB gene Proteins 0.000 description 6
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 description 5
- 238000007400 DNA extraction Methods 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 230000001419 dependent effect Effects 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000004471 Glycine Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 4
- 230000008033 biological extinction Effects 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 4
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 4
- 239000003344 environmental pollutant Substances 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 229910021645 metal ion Inorganic materials 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 231100000719 pollutant Toxicity 0.000 description 4
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- WDNBURPWRNALGP-UHFFFAOYSA-N 3,4-Dichlorophenol Chemical compound OC1=CC=C(Cl)C(Cl)=C1 WDNBURPWRNALGP-UHFFFAOYSA-N 0.000 description 3
- 238000012408 PCR amplification Methods 0.000 description 3
- 238000012300 Sequence Analysis Methods 0.000 description 3
- 239000006180 TBST buffer Substances 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000003776 cleavage reaction Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000033444 hydroxylation Effects 0.000 description 3
- 238000005805 hydroxylation reaction Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 238000001262 western blot Methods 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- GBNHEBQXJVDXSW-UHFFFAOYSA-N 3,4,5-trichlorophenol Chemical compound OC1=CC(Cl)=C(Cl)C(Cl)=C1 GBNHEBQXJVDXSW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 108020003285 Isocitrate lyase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 241000079829 Ralstonia eutropha JMP134 Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 101150100366 end gene Proteins 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 239000011536 extraction buffer Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 239000012160 loading buffer Substances 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- WWGQHTJIFOQAOC-UHFFFAOYSA-N 2,3,5-trichlorophenol Chemical compound OC1=CC(Cl)=CC(Cl)=C1Cl WWGQHTJIFOQAOC-UHFFFAOYSA-N 0.000 description 1
- UMPSXRYVXUPCOS-UHFFFAOYSA-N 2,3-dichlorophenol Chemical compound OC1=CC=CC(Cl)=C1Cl UMPSXRYVXUPCOS-UHFFFAOYSA-N 0.000 description 1
- HXKWSTRRCHTUEC-UHFFFAOYSA-N 2,4-Dichlorophenoxyaceticacid Chemical compound OC(=O)C(Cl)OC1=CC=C(Cl)C=C1 HXKWSTRRCHTUEC-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 101100283604 Caenorhabditis elegans pigk-1 gene Proteins 0.000 description 1
- 235000005881 Calendula officinalis Nutrition 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 101150008132 NDE1 gene Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 108091007187 Reductases Proteins 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 239000011542 SDS running buffer Substances 0.000 description 1
- 101150040974 Set gene Proteins 0.000 description 1
- 240000000785 Tagetes erecta Species 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000008953 bacterial degradation Effects 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 231100000693 bioaccumulation Toxicity 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000010799 enzyme reaction rate Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000037360 nucleotide metabolism Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 239000012146 running buffer Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000007794 visualization technique Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D3/00—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances
- A62D3/02—Processes for making harmful chemical substances harmless or less harmful, by effecting a chemical change in the substances by biological methods, i.e. processes using enzymes or microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/13—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen (1.14.13)
- C12Y114/1302—2,4-Dichlorophenol 6-monooxygenase (1.14.13.20)
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/04—Pesticides, e.g. insecticides, herbicides, fungicides or nematocides
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/20—Organic substances
- A62D2101/22—Organic substances containing halogen
-
- A—HUMAN NECESSITIES
- A62—LIFE-SAVING; FIRE-FIGHTING
- A62D—CHEMICAL MEANS FOR EXTINGUISHING FIRES OR FOR COMBATING OR PROTECTING AGAINST HARMFUL CHEMICAL AGENTS; CHEMICAL MATERIALS FOR USE IN BREATHING APPARATUS
- A62D2101/00—Harmful chemical substances made harmless, or less harmful, by effecting chemical change
- A62D2101/20—Organic substances
- A62D2101/28—Organic substances containing oxygen, sulfur, selenium or tellurium, i.e. chalcogen
Abstract
The invention relates to an artificially modified 2,4-dichlorophenol hydroxylase gene and application, wherein MIX-tfdB and expressed protein thereof, CPs clearance experiments show that MIX-TfdB has higher enzyme activity on 2,4-DCP, 2,5-DCP and 3,4,5-TCP and higher removal rate; 3,4-DCP and 2,3,4-TCP have high removal rate although the enzyme activity is not high; in addition, the CTX3-tfdB gene and the expression protein thereof also show higher CPs removal rate.
Description
Technical Field
The invention belongs to the field of genes, and particularly relates to an artificially modified 2,4-dichlorophenol hydroxylase gene and application thereof.
Background
With the development of industry, chlorophenols are widely used as pesticides, herbicides and preservatives, and have strong bioaccumulation toxicity and three-cause effect. Chlorophenols (CPs) pollute the environment, have large toxicity, and particularly have the property of being difficult to degrade, which always becomes the difficulty of environmental control, and are listed in a blacklist for preferentially controlling pollutants. CPs are mostly aromatic compounds having a cyclic structure, and hydroxylation, one of the most critical steps in the degradation of aromatic compounds, is catalyzed by hydroxylases. Bioremediation is a hotspot for degradation of chlorophenols pollutants, and research on the biodegradation pathway of the herbicide 2, 4-dichlorophenoxyacetic acid (2, 4-D) in the environment has received attention. Thus, many 2,4-D degrading bacteria were isolated from different environments, 2,4-dichlorophenol hydroxylase was originally discovered from 2,4-D degrading bacteria Cupriavidus necator JMP 134. As the 2,4-D degradation mechanism of the bacterium is studied intensively, the enzyme is found to be located on a plasmid contained in C.necator JMP134, and the coding gene is named as tfdB. 2,4-dichlorophenol hydroxylase (2, 4-dichlorophenol hydroxylase, also known as 2,4-dichlorophenol 6-monooxygenase, tfdB) is a flavin hydroxylase, non-covalently bound to a FAD molecule.
TfdB is an enzyme involved in bacterial degradation of 2,4-D, a key step performed by this enzyme is the initial hydroxylation of the benzene ring, and 2,4-DCP (2, 4-dichlorophenol) is considered a natural substrate for TfdB. The activity in all the currently reported substrates is relatively high and the specificity is good. The hydroxylase acts by adding one oxygen atom of molecular oxygen to the aromatic ring and the other oxygen atom participating in the reduction to water, while this step is a conversion of 2,4-DCP to 3, 5-dichloropcatechol depending on the coenzyme NADPH as electron donor, and then the resulting product is finally put into the TCA cycle under the action of a series of hydroxylases and reductases. Only after one or more hydroxyl groups are introduced on the aromatic ring under the action of hydroxylase, the compound is favorable for ring opening and decomposition, and TfdB has certain degradation activity on chlorophenols and homologs thereof. Currently, most of the hydroxylases reported in research do not have the characteristic of substrate universality and are not suitable for industrial treatment of pollutants. Therefore, the construction of the efficient recombinant TfdB has important significance for degrading chlorophenol pollutants by microorganisms.
Disclosure of Invention
The invention provides a2, 4-dichlorophenol hydroxylase gene MIX-tfdB, which is characterized in that the nucleotide sequence is shown as SEQ ID NO. 5.
Another embodiment of the invention provides MIX-TfdB protein, which is characterized in that the amino acid sequence of the MIX-TfdB protein is shown in SEQ ID NO. 6.
Another embodiment of the invention provides a2, 4-dichlorophenol hydroxylase gene CTX3-tfdB, which is characterized in that the nucleotide sequence is shown as SEQ ID NO. 3.
Another embodiment of the invention provides a CTX3-TfdB protein, which is characterized in that the amino acid sequence of the CTX3-TfdB protein is shown in SEQ ID NO. 4.
Another embodiment of the present invention provides the use of the above gene MIX-tfdB or CTX3-tfdB for degrading Chlorophenols (CPs).
Another embodiment of the present invention provides the use of the above MIX-TfdB protein or CTX3-TfdB protein in degrading chlorophenol Compounds (CPs).
Another embodiment of the invention provides application of the genes MIX-tfdB or CTX3-tfdB in preparing recombinant proteins and/or engineering bacteria for degrading chlorophenols. The chlorophenol compound is preferably one or more of 2,4-DCP, 2,5-DCP, 3,4,5-TCP, 3,4-DCP, 2,3,4-TCP, 2,4,5-TCP and 2,3, 5-TCP.
The beneficial effects of the invention are as follows: the invention provides an artificially constructed 2,4-dichlorophenol hydroxylase gene MIX-tfdB and an expressed protein thereof, and CPs clearance experiments show that MIX-TfdB has higher enzyme activity on 2,4-DCP, 2,5-DCP and 3,4,5-TCP and higher removal rate; 3,4-DCP and 2,3,4-TCP have high removal rate although the enzyme activity is not high; in addition, the CTX3-tfdB gene and the expression protein thereof also show higher CPs removal rate.
Drawings
FIG. 1 is an east village harbor act Feng Dong river basin sample collection map; a (110.559836E-19.949968N), B (110.566490E-19.951913N), C (110.580206E-19.945682N); d (110.591480E-19.953493N); e (110.584549E-19.953397N).
FIG. 2 is a metagenomic DNA extraction assay; NM1: hind III DNA Marker, NM2:5kb DNA Marker,S01-S03 is soil sample metagenomic DNA sample, W01-W03 is water sample metagenomic DNA sample.
FIG. 3 is a non-redundant gene set length profile; and (3) injection: the abscissa indicates the length of the ORF sequence, and the ordinate indicates the number of sequences contained in the sequence.
FIG. 4 is a graph of the number of genes co-occurring in soil and water.
FIG. 5 is a functional histogram of Kegg annotated genes.
Figure 6 is a TfdB enzyme protein system evolution analysis (a), tfdB chimeric construction (b).
FIG. 7 is a diagram of SDS-electrophoresis identification, (a) CTX3-TfdB purified protein, (b) MIX-TfdB purified protein, (c) TfdB western blot assay, (a) 1: pET-30 a-to-BL 21 induction expression 2: CTX3-TfdB to BL21 did not induce 3: CTX3-TfdB to BL21 expression pellet 4: CTX3-TfdB to BL21 expression supernatant 5: CTX3-TfdB to BL21 expression purification 6:1×BSA 7:0.75×bsa8:0.5×bsa 9:0.25×bsa 10:0.1×BSA; (b) 1: pET-30 a-to-BL 21 induction expression 2: MIX-TfdB to BL21 did not induce 3: MIXT-fdB to BL21 expression pellet 4: MIX-TfdB to BL21 expression supernatant 5: MIX-TfdB to BL21 expression purification 6:1×BSA 7:0.75×bsa8:0.5×bsa 9:0.25 XBSA.
FIG. 8 is a graph of CTX3-TfdB enzyme activity assay.
FIG. 9 is a graph of MIX-TfdB enzyme activity assay.
FIG. 10 is a graph (a) showing the effect of different concentrations of FAD on TfdB enzyme activity, and a graph (b) showing the effect of different temperatures on TfdB.
Fig. 11 is a graph of the effect of pH on TfdB enzyme activity (a) and of the effect of ions on TfdB (b).
FIG. 12 is a graph of enzyme activities of different substrates, CTX3-TfdB (a), MIX-TfdB (b).
FIG. 13 is a chart of CPs removal rates, CTX3-TfdB (a), MIX-TfdB (b).
FIG. 14 is a map of plasmid pET-30a used in the present invention.
Detailed Description
In order to better understand the technical content of the present invention, the following provides specific examples to further illustrate the present invention.
The embodiment of the invention relates to a specific reagent, sample collection and general experimental operation method, which are as follows:
1. primary reagent and solution configuration
1) LB medium: pancreatic protein (Tryptone) 10g; 5g of yeast extract (yeast extract); 10g of sodium chloride (NaCl) and distilled water were added to a volume of 1L. The pH value is 7.2-7.4 (hand-held pH meter), and the solid culture medium is added with 1.5% agar. 121 ℃. And (5) sterilizing by high-pressure steam for 20 min.
2) TE buffer dissolution: 10mM Tris-HCl,1mM EDTA,pH =8.0;
3)J Buffer:0.1M Tris-HCl、0.1M EDTA、0.15M NaCl,pH=8.0;
4) Restriction enzymes were purchased from Thermo company;
5) DNA Marker (No. B500347), DNA Marker lH, sanPrep column type PCR product purification kit (No. B518141), sanPrep column type plasmid DNA miniextraction kit (No. B518191), ready-to-use seamless cloning kit (No. B632219), isocitrate lyase (ICL) activity detection kit (No. D799839), ECL hypersensitive chemiluminescence kit (No. D6010139), 1xPBS buffer and SDS-PAGE Preparation kit (No. C631100) were all purchased from Shanghai Biotechnology;
6) The TureColor trichromatic pre-dye Marker (No. c 510010) contains 10 purified recombinant proteins (10, 17, 25, 33, 40, 53, 70, 95, 130, 180 kDa) in total from 10kDa to 180kDa, with the 70kDa band being orange, the 10kDa band being a mixture of blue and yellow bands, the remaining bands being blue. Suitable as a protein molecular weight standard for SDS-PAGE and Western.
7) 100mg/mL ampicillin (Amp): 1g of ampicillin powder is weighed and dissolved in 10mL of distilled water, filtered and sterilized by a sterile 0.22 mu m filter, and then packaged into 1.5mL of EP tube, stored at-20 ℃, and diluted 1000 times when in use;
8) 20mg/mL kanamycin (Kan): weighing 0.2g of kanamycin powder, dissolving in 10mL of distilled water, filtering and sterilizing by a filter dissolved in 0.22L in an ultra clean bench, subpackaging into 1.5mL of EP (European patent application) pipes, and preserving at-20 ℃ until the working concentration reaches 10ug/mL;
9) Agarose gel: 0.5g agarose was weighed out and dissolved in 50mL of 0.5 XTBE solution: weighing electrophoresis buffer solution, heating for 3min in a microwave oven at 300W, standing at normal temperature for about 15min, cooling to 50deg.C, sucking 3uL sample containing nucleic acid dye GVIII and 5uL DNA with a pipetting gun, mixing, and adding into sample hole;
10 0.5M IPTG: weighing 2.38g of IPTG (isopropyl-isopropyl M thiogalactoside) and dissolving in 20mL of distilled water, filtering and sterilizing by using a 0.22 filter, subpackaging into 1.5mL of EP pipe, and storing at-20 ℃;
11 5 XSDS-PAGE protein loading buffer: purchased from Shanghai assist, san Biotech Co.
12 5 XTris-glycine running buffer: tris base 15.1g,Glycin 94g,5g SDS, adding three distilled water for dissolution and then fixing the volume to 100mL. When in use, the three distilled water is diluted into 1 XTris-glycine electrophoresis buffer solution;
13 Coomassie brilliant blue staining solution): coomassie brilliant blue R250 g, methanol 180mL, acetic acid 40mL, add dd H 2 Filtering the mixture into a brown bottle by using filter paper after fully and uniformly mixing, and preserving the mixture at normal temperature;
14 Fast decolorization liquid): taking 450mL of distilled water, 450mL of ethanol and 100mL of acetic acid, and fully and uniformly mixing;
15 Slow decolorizing liquid: 700mL of distilled water, 200mL of methanol and 100mL of acetic acid are measured and fully and uniformly mixed;
16 Transfer buffer 1000mL: glycine 2.9g,Tris base 5.8g,SDS 0.37g, 200mL of methanol and ddH2O triple distilled water were added to volume 1000mL.
17 PBST buffer: PBS containing 0.5mL/L Tween-20 (Tween-20).
18 Phosphate buffered saline (pH 7.4): 8g NaCl,0.2g KCl,1.44g Na 2 HPO4 and 0.24 g KH 2 PO4。
2. Sample collection
During the ebb period of 7 months in 2019, five sampling parties are set along the act Feng Dong river to collect water samples and soil samples, and the sampling parties cover the upstream, middle and downstream of the river (fig. 1). Firstly, a five-point sampling method is adopted to collect soil samples on each sampling side, sundries such as leaves, grass and the like covered on surface soil are removed, 4 repetitions are taken, 4 soil samples are obtained, and 20 soil samples are obtained for 5 sampling points. All soil samples were thoroughly mixed to remove debris and then stored in sterile plastic bags. A detailed record of the label was made, which was attached to the outside of the sample bag. The water samples were collected on the shore while soil samples were taken, a total of 20 water samples were taken at 5 sampling points, and all water samples (20 total L) were thoroughly mixed. And collecting microorganisms in the water body sample into a sterile centrifuge tube through centrifugation, and placing the collected soil and water body sample at-80 ℃ for storage after treatment.
3. Extraction of environmental (soil and water) microbial metagenomic DNA
Metagenomic DNA was extracted by direct lysis (He Jizheng et al 2012; zhao Yudong, zhou Jun, what, clear, 2012), the operations described below are described with respect to soil samples, and water sample metagenomic DNA extraction operations reference soil samples.
1) The soil was removed from-80℃and thawed at room temperature for about 30min, and 5g of the soil sample was weighed into a 100mL centrifuge tube.
2) To the sample, 14. 14mL DNA extraction buffer and 100. Mu.L proteinase K (10 mg/mL) were added, and the mixture was mixed.
3) Centrifuge tube was shaken horizontally at 37℃and 225rpm for 30min.
4) 2mL of 20% SDS was added, the mixture was cooled to room temperature by gently inverting the mixture several times every 15min in a 65℃water bath for 2 hours.
5) Centrifuge at 6000g for 10min at room temperature, collect supernatant and transfer to a new centrifuge tube.
6) To the pellet was added 4.5. 4.5mL DNA extraction buffer and 0.5mL 20% SDS, and gently vortexed until well mixed.
7) Water bath at 65 ℃ for 10min.
8) Centrifuging at 8000g for 6min at room temperature, collecting supernatant, and mixing with the supernatant.
9) The operations 6, 7, 8 were repeated once.
103 times of extraction with equal volumes of phenol: chloroform (1:1) is mixed, shaken well, centrifuged for 10min at 4 ℃ and 12,000g, mixed well and horizontally reversed for about 10 times.
11 Transfer to a new 100mL centrifuge tube, add an equal volume of chloroform: isoamyl alcohol (24:1), the level is reversed for about 10 times, and after being evenly mixed, the mixture is centrifuged for 10min at 4 ℃ and 12,000 g.
12 Transferring the supernatant again to a new centrifuge tube, adding 0.6 times volume of isopropanol, precipitating at room temperature for 1h, centrifuging at room temperature for 20min at 12,000g, and collecting the precipitate.
13 Washing the precipitate twice with pre-chilled 70% ethanol, gently mixing, and centrifuging at 4℃for 2min at 12,000 rpm/min.
14 100-500. Mu.L TE solution was added to the centrifuge tube, left overnight at 4℃and transferred to a 1.5mL centrifuge tube, centrifuged at 10,000rpm for 2min, and the supernatant was removed from the excess impurities.
4. Metagenomic sequencing
The extracted soil and water DNA samples were kept in dry ice, sent to Shanghai Meji Biotechnology (http:// www.majorbio.com) and double-ended by HiSeq 4000 platform (Inc., san Diego, calif., USA). Mainly comprises the following steps: preparing a library; breaking the genomic DNA into small fragments of several hundred bases (or less); terminal end adaptor; generating a DNA cluster; sequence information of the template DNA fragments is obtained by applying the principle of sequencing while synthesizing.
5. Microbial diversity analysis
The quality control is carried out on the original sequencing data of the macro genome in the environment of the mangrove forest in the east village harbor by using the software Seqprep, invalid bases in the original data are removed, and the reliability of data analysis and the accuracy of results are improved by high-quality data. ORF prediction was further performed. Selecting the gene with the length of the gene sequence being more than or equal to 100bp, and translating the gene into an amino acid sequence. All gene sequences predicted in the samples were clustered using CD-HIT software (default parameters: 90% identity,90% coverage). Constructing a non-redundant gene set explores commonalities and differences between different samples. And comparing the KEGG databases to obtain KEGG annotation profiles corresponding to the genes and carrying out statistics. The non-redundant gene set sequences were aligned to the KEGG gene database (GENES) using DIAMOND (parameters: blastp; E-value. Ltoreq.1E-5). The Venn diagram can be used for counting the number of species, functions or genes shared and unique among multiple groups or multiple samples, and can be used for clearly showing the composition similarity and overlapping condition among environmental samples.
Species, functions or gene abundance of each sample is counted on species, genes or functional layers, and dominant species, genes or functional compositions of communities are intuitively researched through a column diagram visualization method. Clustering is typically performed according to similarity of species (genes, functions) or abundance among samples, and the results are presented on a community hetmap, reflecting differences between different samples by color contrast. Inter-group significance difference test species between different groups (or samples) of microbial communities are analyzed according to the obtained reads abundance data to obtain species, functions or genes with obvious differences between the samples.
Table 1: software and parameters for each analysis of the study
6. Functional gene annotation screening
The annotation of gene functions depends on the gene structure and gene sequence, and functional information of the gene is obtained by comparing the gene sequence or protein sequence with a database, and finally, the functional annotation of the predicted encoding gene is performed (Li Tiezhu, etc., 2012). Based on the sequencing results, gene prediction was performed by software Glimmer 3.02 and Gene mark, ORF prediction was performed on predicted genomic components and possible encoding genes. And (3) constructing a blast sequence alignment database, and screening out genes possibly encoding specific functional proteins in the predicted genes through a blast alignment program (Zhang Enmin, marigold, dongzheng, 2009).
7. Plasmid DNA extraction
1) Plasmid DNA was extracted using a plasmid DNA miniextraction kit.
2) Single colonies were picked and placed into LB medium containing the corresponding antibiotics. Shaking table at 37 deg.C and 200rpm overnight;
3) 8,000rpm, centrifuging for 2min, pouring out the supernatant, and sucking out the redundant culture medium;
4) Adding 250 mu L buffer P1 into the bacterial precipitate, and blowing or vibrating until bacterial is thoroughly suspended;
5) Adding 250 mu L buffer P2, immediately and gently reversing and uniformly mixing, and standing at room temperature for 3min;
6) Adding 350 mu L buffer P3, immediately slightly inverting the mixture for about 5 times, and fully and uniformly mixing;
7) Centrifuging at 12,000rpm for 10min, transferring the supernatant to a new centrifuge tube, and discarding the precipitate;
8) Adding 0.5mL of isopropanol and uniformly mixing; centrifuging at 12,000rpm for 10min, carefully decanting the supernatant;
9) Adding 0.7mL of 70% ethanol solution, gently mixing, centrifuging for 2min, and removing the supernatant;
10 Repeating the 9 th step; centrifuging to volatilize ethanol;
11 Naturally drying for 20min, adding 40 μl TE solution, and storing at-20deg.C for subsequent test.
8. Gene PCR amplification
Primers (containing Xho1 and Nde1 cleavage sites) were designed to amplify the complete sequence of the gene by software primer 5.0 based on the predicted sequence of the gene of interest. PCR amplification of the DNA fragments was performed using the designed primers, and the PCR reaction system is shown in Table 2.3. Basic procedure for PCR amplification: pre-denaturing at 95 ℃ for 5min; carrying out denaturation at 95 ℃ for 1min; annealing at 55-70 ℃ for 1min; extending at 72 ℃ for reaction for 1min; then the reaction is carried out for 10min at 72 ℃; denaturation to extension was carried out for 30 cycles.
TABLE 2 PCR reaction System
9. Seamless cloning
1) Purifying the target gene PCR product and the carrier fragment after double enzyme digestion by using a purification kit;
2) Adding target genes, vector fragments and seamless cloned enzyme into the same EP tube according to an enzyme-linked reaction system;
3) An enzyme cleavage reaction system (Table 3), an enzyme-linked reaction system (Table 4);
4) Water bath at 50 ℃ for 30min;
5) Thawing HD5 alpha competent cells on ice;
6) Mixing enzyme-linked product and competent cells uniformly (inhibiting vortex), and placing on ice for 30min;
7) Placing in a metal water bath kettle at 42 ℃, and immediately transferring to ice for cooling for 2min after heat shock for 45 s;
8) Adding 450 mu L of LB liquid medium, and shaking at 200rpm at 37 ℃ for 1H;
9) Centrifuging at 12,000rpm and 4 ℃ for 2min, and removing 300 mu L of supernatant in a super clean bench;
10 Blowing and mixing the bacterial liquid in the EP pipe by a pipetting gun, uniformly coating the bacterial liquid on an LB plate containing corresponding antibiotics by a coating rod, and culturing the bacterial liquid in an incubator at 37 ℃ for 9-12H in an inverted manner;
11 Picking single colonies with equal size, and adding the single colonies into a liquid LB culture medium for overnight culture at 37 ℃;
12 Performing colony PCR, recombinant plasmid extraction PCR, enzyme digestion and other verification methods;
13 Screening positive transformants, and sequencing the transformants in Shanghai biological limited company;
14 DNA sequence analysis was performed using the Vector NTI Suite 11 software package from Invitrogen.
TABLE 3 cleavage reaction System
TABLE 4 enzyme-linked reaction system
10. Gene-induced heterologous expression
1) Inoculating the constructed expression engineering strain into LB culture medium containing corresponding antibiotics, and activating the expression strain overnight;
2) The following day was transferred to liquid LB medium containing the corresponding antibiotic in an amount of 1%, shaking culture at 37deg.C for about 2H to OD 600 About 0.6, adding IPTG with proper concentration to 0.1-0.5-mM, and culturing 8H-20H;
3) No-load induction with IPTG as control, 2 parts of expression strain are transferred, one part is added with IPTG, and one part is used as negative control without IPTG;
4) Trying different temperatures, IPTG concentration and expression time, optimizing an expression system, and realizing soluble expression as far as possible;
5) Collecting thalli at 8,000g for 5min, washing 1-3 times with PBS solution, and washing 1 time with sterile water;
6) Adding a proper amount of PBS buffer solution, and treating for 5-20min in ultrasonic crushing until the liquid is clear (parameters: small probe power 20%, working 5s, interval 5 s);
7) Centrifuging to collect supernatant and precipitate respectively; the precipitate was washed 2 times with 1mL of PBS buffer, then 100 μl of PBS buffer was added to blow suspension;
8) Centrifuging the protein products of the expression strain and the reference strain for 5min at 10,000rpm, and collecting the supernatant and the precipitate respectively; washing 1-2 times with 1mL PBS buffer, mixing with 50. Mu.L PBS buffer, and performing SDS-electrophoresis analysis;
9) Bio-Rad densitometry scanning: scanning the protein gel using G800 and saving the picture;
10 Protein band SDS plots and their concentrations were analyzed using quality One software (Zhang et al 2012);
11 Expression verification is correct and can be expressed in a large amount, and the expression is induced by culturing in a 500mL culture flask.
11. Purification of expressed proteins
1) The obtained protein supernatant was mixed with Ni-NTA at a ratio of 1:4, mixing;
2) Placing the adsorption column on ice, and slowly and uniformly mixing with a 200rpm shaking table for 2H to fully combine the protein and Ni ions;
3) Opening a liquid outlet of the adsorption column to enable the leaching liquid to flow out, and collecting the leaching liquid;
4) Different concentrations of imidazole were configured: 20mM,50mM,70mM,130mM,170mM,202mM, 210mM, wash buffer with imidazole concentration of 10mM and Elutation buffer with imidazole concentration of 250mM are prepared; mixing the two reagents in proportion to obtain imidazole buffers with different concentrations;
5) 200. Mu.L of pre-chilled Wash buffer was added and the solution was placed on ice for 5min before releasing the Wash. Eluting for multiple times until the leaching solution is subjected to SDS-PAGE and has no protein band, and repeating the steps for one time;
6) Sequentially eluting with prepared imidazole concentration gradients, washing each gradient for at least 5 times, performing SDS-PAGE to obtain different elution effects of target proteins under different imidazole concentrations, and selecting the concentration with the best effect for the next time;
7) SDS-PAGE analysis of the eluate was performed and the eluate was placed at-20℃for further use.
12. SDS electrophoresis analysis
1) And (3) glue preparation: when the separating gel is prepared, adding a proper amount of n-butanol to eliminate bubbles, preparing concentrated gel after the separating gel is solidified, immediately inserting into a 1mm comb, and standing for 30min. Solidifying the gel with the concentrate for later use;
2) Sample treatment: mixing 16 mu L of protein sample with 4 mu L of 5 XSDS dye liquor buffer, and boiling for 5min;
3) Centrifuging at a low temperature of 4 ℃ for 12,000g and 5min, carefully sucking the supernatant into gel holes;
4) Using protein maker as a standard, 1%SDS running buffer (Tris15.1g, glycine 94g,SDS 5g,5,000mL H 2 O);
5) Performing constant voltage electrophoresis at 80V for 30min until sample protein is compressed and enters into the separation gel, regulating the voltage to 110V, and ending the constant voltage electrophoresis until bromophenol blue reaches the lower end of the gel;
6) Coomassie brilliant blue staining: carefully peeling the gel, washing, staining with coomassie brilliant blue for 30min, and placing on a horizontal oscillator;
7) Decoloring: washing the gel with distilled water after dyeing, adding 50mL of quick-release buffer solution, decoloring for 30min, adding slow-release buffer solution, and continuously shaking on a shaker until clear protein strips can be observed visually; and scanning by using a gel imager, analyzing and storing the picture.
13、Western blot
The protein is detected by using Western Blot, and the specific operation steps are as follows:
1) Electrophoresis: taking 16 mu L of protein sample, adding 4 mu L of 5 XSDS-PAGE loading Buffer, heating in boiling water for 5min, centrifuging at 12,000rpm for 5min, taking 16 mu L of supernatant, performing constant voltage electrophoresis at 80V for 45min, and performing constant voltage electrophoresis for 120min at a regulated voltage of 110V;
2) Transferring: cutting PVDF film consistent with the albumin glue, soaking in methanol solution for about 20s for activation, and placing the activated PVDF film and filter paper together into film transferring liquid for soaking. After electrophoresis, carefully taking out the protein gel, washing with distilled water after degumming, cutting off the area without protein, and soaking in the transfer film liquid; adopting a wet transfer method to transfer films according to the following sequence: the plate cathode, the sponge, the three layers of filter paper, the SDS-PAGE gel, the PVDF film, the three layers of filter paper and the plate anode are placed well and tightly sealed, and bubbles between the gel and the film and the filter paper are required to be removed during sealing, so that the influence on film transfer is avoided. Adding 1L of film transfer liquid into an electrophoresis tank, placing the electrophoresis device into an ice-water mixture, transferring film at 100V for 1H, and properly changing film transfer time according to the molecular mass of protein;
3) Closing: after the transfer, the PVDF membrane was transferred to a clean plastic box, washed with PBST or TBST at 100rpm with shaking for 10min, and repeated three times. Adding PBS (containing 1% BSA) blocking solution to block at normal temperature for 1H or at 4 ℃ for overnight after cleaning;
4) Antibody incubation: after the end of the blocking, discarding the blocking solution, washing for 10min by using PBST or TBST at 100rpm in an oscillating way, repeating for three times, and then adding primary antibody (1:1,000) into the blocking solution for incubation for 1H; adding a secondary antibody for incubation for 1H after washing the membrane;
5) Color development: after the incubation, discarding the incubation liquid, washing with PBST or TBST at 100rpm under shaking for 10min, repeating for three times, performing color development by using ECL super-sensitive chemiluminescence kit, uniformly mixing 1mL of the solution A of the chemiluminescence kit with 3 mu L of the solution B, uniformly spraying on the surface of the membrane by using a pipetting gun, sucking the redundant luminescence solution with filter paper after 1min, performing exposure imaging in a gel imager, and preserving.
14. Enzyme Activity assay
The enzyme activity was measured by ultraviolet spectrophotometry, and the enzyme activity of the enzyme was calculated indirectly by measuring the decrease in absorbance of NADPH at 340nm (Liuyang, 2011). The method for measuring the enzyme activity comprises the following steps:
1) Placing enzyme solution to be tested, 2,4-DCP mother liquor (prepared by acetone), NADPH mother liquor, phosphate buffer solution and ddH on ice in advance 2 O;
2) To a 1.5mL EP tube, 200. Mu.L of 1mM 2,4-DCP mother liquor, and 400. Mu.L of 1mM NADPH mother liquor were added and left on ice for use;
3) After 50mM phosphate buffer (pH 7.5) was added thereto, 100. Mu.L of the enzyme solution was rapidly added thereto, and after mixing, the change in the ultraviolet absorbance at 340nm was measured at 25 ℃.
The units of TfdB enzyme activity are defined as: the amount of TfdB enzyme required to consume 1. Mu. Mol of NADPH in 1min was measured at 340nm wavelength at 25℃under standard conditions.
TfdB (U/mg) =ΔA/mol extinction coefficient×d×V inverse total×10 9 (V sample×Cpr)/(T)
V inverse total: total volume of reaction, 1X 10 -3 L is; v sample: add sample volume, 0.1mL; NADH molar extinction coefficient, 6.22×10 3 L/mol/cm; d:1mL quartz cuvette optical path, 1cm; cpr: sample protein concentration, mg/mL; v extraction: adding 1mL of the volume of the extracting solution; t: reaction time, 1min; unit conversion coefficient, 1 mol=10 9 nmol。
The study carried out the measurement calculation on the TfdB enzyme dynamics data to further study the influence of different factors on the enzymatic efficiency. Ladder for setting temperatureThe temperature is15 ℃,20 ℃, 25 ℃,30 ℃, 35 ℃, 40 ℃, 45 ℃ and 50 ℃; the pH value is 4,5, 6, 7, 8, 9 and 10; metal ions have Mn 2+ 、Mg 2+ 、Cu 2+ 、 Fe 2+ 、Zn 2+ 、K + 、Ca 2+ The method comprises the steps of carrying out a first treatment on the surface of the The TfdB activity under the above conditions was measured separately. The specific process is similar to that described in document 2.2.15. Because the enzyme has higher sequence and structural similarity with FAD dependent hydroxylase. We further studied the cofactors required for hydroxylase activity of CP homologs, adding 0.005mM FAD to the enzyme reaction system, and found that the rate of enzyme reaction was indeed increased, and then the effect of different concentrations of FAD on the enzyme activity of TfdB was measured to different extents.
15. Substrate-universality of TfdB enzyme
In the enzyme reaction system of the enzyme, different chlorophenol compound substrates are added, the types and physicochemical properties of the chlorophenol compounds are shown in table 2.6, and the enzyme activities of TfdB on various chlorophenol compounds are measured. High enzymatic activity towards CPs generally results in correspondingly high CP removal rates. And measuring the CPs removal rate after 60min of reaction by using an ultraviolet spectrometry method. The removal rate of CPs is the concentration of NADPH reducing amount divided by the amount of initial NADPH. In the TfdB enzyme reaction system, different CPs substrates are added, the initial NADPH value is measured, then the mixture is put into a water bath kettle at 37 ℃ to react for 60min, and the NADPH value is measured. And (5) sequentially calculating the removal rate of TfdB on different CPs substrates.
TABLE 5 TfdB substrate Compounds and physicochemical Properties thereof
16. Protein target molecule docking
TfdB target protein structures are obtained by using Swiss-Model online server homology modeling. After the related small molecules in the protein molecules are deleted by using the Pymol2.1 software, the TfdB protein molecules are imported into the Auto Dock Tools-1.5.6 software to delete water molecules, add hydrogen atoms and set atom types, and finally the TfdB protein molecules are saved as a pdbqt file. The 2,4-Dichlorophenol of the compound structure is from a PubCHem database, the energy of the 2,4-DCP is minimized through Chem3D, the 2,4-DCP is converted into a mol2 format, the three-dimensional structure of the 2,4-DCP is imported into Auto Dock Tools-1.5.6 to execute the same operation as the previous step, and finally the three-dimensional structure of the 2,4-DCP is saved as a pdbqt file. The treated 2,4-DCP is used as a molecular ligand, tfdB protein is used as a receptor, and the central position (x_center= -63.12, y_center= -34.424, z_center= -9.883) and the length, width and height of the Grid Box are determined according to the interaction of small molecules and targets are all set to be 40 multiplied by 40. Finally, batch molecular docking is carried out through Auto Dock, the result is further analyzed, and the combination effect of the 2,4-DCP and TfdB is visualized by using Pymol2.1 software. And evaluating the final docking structure based on the binding free energy.
Analyzing the action mode of the compound and the target protein to obtain the action condition of the compound and the protein residue, such as generated hydrogen bond action, pi-pi interaction, hydrophobic interaction and the like, and referring to the butt joint scoring of the compound, judging whether the compound to be screened has a certain activity action (An Song, 2020).
Note:Binding energy fuction:
ΔG bind =C lipo-lipo ∑f(γ lr )+C hbond-neut-neut ∑g(Δr)h(Δα)+C hbond-neut-charged ∑g(Δr)h(Δα)+ C hbond-charged-charged ∑g(Δr)h(Δα)+C max-metal-ion ∑f(r lm )+C rotb H rotb + C polar- phob V polar-phob +C coul E coul +C vdw E vdw +solvationterms
EXAMPLE 1 mangrove wetland water sample and soil sediment metagenomic DNA sequencing
The extracted metagenomic DNA was visualized by agarose gel electrophoresis as shown in FIG. 2. The band of the metagenomic DNA is more than or equal to 23kb, which indicates that the extracted DNA has better integrity. The quality detection of DNA concentration and purity by NanoDrop One, absorbance at A260/A280 was about 1.8, indicating that the metagenomic DNA was relatively pure with little contamination by proteins or other impurities. The results also indicate that the quality of the metagenomic DNA meets the sequencing requirements.
Metagenomic sequencing generates a large amount of data, with the total number of all sample genes before redundancy elimination being 10, 321, 205. The average number of raw readings in soil and water samples was 99, 317, 796 and 98, 984, 089, respectively. The quality control results of the metagenome sequences are shown in Table 6 and Table 7, and the total number of genes after redundancy removal is 36 and 590; the average number of quality control readings in soil and water samples after quality control was 98, 645, 909 and 97, 975, 913. From the data, it can be deduced that after the quality control of the sequences, the soil sample and the water sample account for about 99% of the original readings, and the soil sample and the water sample account for about 98% of the original base number. The quality control result of the sequence intuitively reflects that the sequencing quality of soil and water samples is good. By constructing the non-redundant gene set, the base sequence of the non-redundant gene set gene is obtained. The differences between the different samples can be reflected, and most of the sequences were found to be distributed between 200bp and 1,000bp, and a few were distributed at other lengths (FIG. 3). And processing the sequenced original data, removing the gene sequence with interference, and obtaining effective quality control data, thereby providing guarantee for the accuracy of subsequent bioinformatics analysis.
TABLE 6 statistical tables of number and length of genes before and after redundancy removal
TABLE 7 quality control statistics of metagenomic sequences
Functional gene annotation screening
And (3) performing macro genome sequencing to generate a large amount of data, performing quality control to obtain high-quality control data, and performing analysis and statistics on macro genome data annotation results through comparison and annotation functions with a plurality of functional databases to obtain all gene function information in the east-to-west harbor mangrove environment. First, the genes in soil and water are compared, and the result shows that the specific genes in soil are 11,829, the specific genes in water are 14,003, and the common genes in water environment and soil environment are 10,758. The genetic profile between soil and water reveals that there is no independence between soil and water, and there is a relationship between the two habitats where microorganisms interact and are isolated from each other, as shown in fig. 4.
Annotating the macro genome data of the environment of the east village harbor mangrove forest by utilizing a KEGG database, and establishing a KEGG annotated gene function histogram. From FIG. 5, it can be seen that 21 different types of gene functions (the ratio is greater than 1%) are found out from the gene set by comparison with KEGG database and annotation analysis, wherein the four gene functions with the highest ratio are carbohydrate metabolism, amino acid metabolism, energy metabolism and nucleotide metabolism respectively. The obtained gene was compared with the KEGG gene database (Genes), and biological pathways of the corresponding functions in which the gene participated were obtained from the annotated gene analysis, and analysis of the pathways of the gene helped to further study the functions of the gene.
And finally obtaining the functional information of the genes through gene annotation. 4901 sequences are coded, and 17 genes which code for different enzyme functions are finally screened according to the functions of gene annotation, sequence integrity and the like, as shown in table 8. The 17 functional enzyme genes were further analyzed, and primers were further designed according to the sequences. The cloning and the expression of 7 genes are successfully completed by respectively carrying out seamless cloning and heterologous expression, and the gene sequence for coding TfdB is selected for subsequent experiments and analysis based on sequence analysis similarity, integrity and specificity of gene functions.
Table 8 identification of 17 functional enzyme genes
The preselected and screened target gene sequence information is clipped into primer 5.0, and the PCR primer sequence information is edited and synthesized by Shanghai Biotechnology, inc., see Table 9 in detail.
TABLE 9 primer information for target gene design
Note that: lower case letters in the F primer sequences represent homologous sequences at the upstream vector end of the 5 'end, and upper case letters represent forward amplified sequences specific for the 5' end gene; the lowercase letters in R indicate 5 'end downstream vector end homologous sequences, and the uppercase letters indicate 5' end gene-specific reverse amplification sequences.
Example 2TfdB sequence analysis and construction
The metagenome sequencing fragment is subjected to homology search in a Non-redundant UniProtKB/SwissProt sequences database by using a Blastp program provided by NCBI, found that a TfdB gene with the size of 939 bp codes 313 amino acid residues, has the greatest similarity (similarity of 50.32 percent and coverage of 98 percent) with the sequence of 2,4-dichlorophenol 6-monooxygenase (P27138.1) in the database, and is a novel 2,4-dichlorophenol hydroxylase gene, the inventor names the gene as TfdB-M153, the nucleotide sequence of which is shown as SEQ ID NO.1, and the coded protein (313 amino acids, the sequence of which is shown as SEQ ID NO. 2). By sequence comparison, the deletion of the C-terminal sequence of the TfdB-M153 gene is found, which is caused by the technology of metagenome sequencing. We have also found that a TfdB gene of 1749bp, which codes for 582 amino acid residues, is a novel 2,4-dichlorophenol hydroxylase gene, which has been named CTX3-tfdB by the inventor, and has a nucleotide sequence shown as SEQ ID NO.3, and a protein (582 amino acids, the sequence shown as SEQ ID NO. 4) encoded by the gene. Based on CTX3-tfdB gene, the deleted part of TfdB-M153 is complemented by utilizing a multi-sequence seamless cloning technology (figure 6), a novel TfdB gene with 1758bp is constructed, 585 amino acid residues are encoded, the similarity with Non-redundant UniProtKB/SwissProt sequences database 2,4-dichlorophen 6-monooxygenase (Q8KN28.3) is highest (the similarity is 44.21 percent and the coverage is 97 percent), the novel artificially constructed 2,4-dichlorophenol hydroxylase gene is named as MIX-tfdB by the inventor, the nucleotide sequence of the gene is shown as SEQ ID NO.5, and the encoded protein (585 amino acids are shown as SEQ ID NO. 6)
Example 3
1. TfdB gene expression and purification
To determine whether the recombinant protein obtained had TfdB bioactivity, two sets of enzyme activity control experiments were set up. The first group adds pET30a to BL21 recombinant protein in the enzyme reaction system to determine the enzyme activity of the enzyme reaction system, and the second group adds TfdB to BL21 recombinant protein in the enzyme reaction system to determine the enzyme activity of the enzyme reaction system, and analysis is carried out and a detection dynamics curve of TfdB enzyme activity is drawn. The two TfdB genes are expressed in E.coli BL21 (DE 3) as host cell.
The effect of different temperatures, different IPTG concentrations and different induction times on TfdB protein expression was explored separately, wherein the optimal induction concentration of recombinant CTX3-TfdB was 5 μl. The induction of 12H at 28℃resulted in FIG. 7a, which shows a slower protein expression rate when the temperature was lower, whereas the optimal induction concentration of recombinant MIX-TfdB was 5. Mu.L, and the induction of 8H at 16℃was used as the optimal temperature and optimal induction time for the expression of the foreign protein (FIG. 7 b). The recombinant protein N segment has 6 XHis, the recombinant protein is purified by adopting an affinity ion chromatography, and the protein concentration of the purified protein is measured by a Bradford method, so that the protein concentration of the purified protein is 0.138mg/mL and 0.079mg/mL respectively. The purified protein of interest was detected with an anti-His tag monoclonal antibody, which indicated that the protein of interest was a recombinant protein containing a 6 xhis tag (fig. 7 c).
2. TfdB enzyme Activity assay
Under the optimal expression conditions, the expressed proteins were subjected to enzyme activity assays. The enzyme assay during the removal of CPs was determined by monitoring the decrease in absorbance at 340nm after NADPH substrate dependent oxidation. To determine whether the recombinant protein obtained in this study had the biological activity of the enzyme, the OD size was not changed substantially within ten minutes in the reaction system without TfdB addition, the reaction began to proceed after TfdB addition, the OD value began to decrease, and the FAD concentration of 0.005mM had some promotion of the TfdB enzyme activity. The total time for the whole reaction test was 10min (FIG. 8).
The decrease in NADPH was measured at 340nm absorbance to reflect TfdB enzyme activity. Wherein the absorbance of CTX3-TfdB enzyme activity reaction for 1min is reduced by 0.145, and according to the protein concentration of 0.138mg/mL, the formula TfdB (U/mg) =DeltaA/molar extinction coefficient x d x V x 10 is calculated 9 ÷(V×Cpr)÷T=1.68 μmol/(mg·min)。
Absorbance decrease of 0.086 in 1min in MIX-TfdB enzymatic activity reaction, according to protein concentration of 0.079mg/mL, calculated as: tfdB (U/mg) =ΔA/mol extinction coefficient×d×V×10 9 ÷(V×Cpr)÷T=1.75 μmol/(mg·min)
When the TfdB sequence is analyzed, the enzyme is possibly a FAD dependent enzyme, the enzyme reaction system is added with 0.005mM FAD, the enzyme reaction rate is indeed increased, then the TfdB enzyme activity is analyzed by different concentrations of FAD, and the TfdB enzyme activity is promoted to different degrees by different concentrations of FAD, wherein the enzyme activity promotion by CTX3-TfdB is higher by the added concentration of 0.005mM FAD. The enzyme activity promoting effect on MIX-TfdB was not evident by the addition of different concentrations of FAD (fig. 10 a).
In order to explore the influence of various factors on TfdB enzyme reaction, experimental analysis is carried out on the optimal pH value, the optimal temperature, the optimal metal ions and the optimal cofactors. The optimum temperature of the enzyme was determined in the temperature range of 0℃to 55 ℃. CTX3-TfdB enzyme has highest activity at 20 ℃ and higher catalytic activity at 20-40 ℃, MIX-TfdB enzyme has highest activity at 40 ℃ (figure 10 b), and the highest optimal enzyme activity can be related to the special habitat of mangrove.
The enzyme activity is higher under neutral conditions, whereas the stability of the enzyme is worse under other conditions, when the pH is below 6.0 or above 8.0, the CTX3-TfdB enzyme activity is lower. The CTX3-TfdB enzyme has optimal enzyme activity at pH 7.4. The optimum pH for MIX-TfdB was 6.0. The MIX-TfdB enzyme has better stability in a wider range (figure 11 a), and the results show that the MIX-TfdB enzyme can play a normal catalytic role under weak acidic condition or neutral condition. This feature may be related to the strong acidic habitat conditions of mangrove.
The enzyme activity was then determined by adding different ions to the enzyme solution, and the results showed (FIG. 11 b) Mg 2+ Has promoting effect on CTX3-TfdB enzyme activity, and Cu 2+ 、Zn 2+ Has inhibiting effect on CTX3-TfdB enzyme activity. Mg of 2+ 、Ca 2+ Has inhibitory effect on MIX-TfdB enzyme activity. Fe (Fe) 2+ It is presumed that the CTX3-TfdB enzyme activity is promoted by binding of a metal ion to a certain group of the enzyme molecule, resulting in a decrease or loss of the enzyme activity.
3. Enzyme substrate specificity assay
The substrate specificity of the enzyme was determined using chlorophenol substrates of different structures. The present study uses ultraviolet spectrophotometry to detect TfdB enzyme activity. Under the condition of 37 ℃, the reaction rates of different chlorophenol compound substrates are catalyzed by enzymes, and the result proves that TfdB has different degradation activities on the selected chlorophenol compound substrates, and the addition of the FAD with proper concentration can increase the reaction rate, so that the addition of the FAD has a certain pushing effect on the reaction of the TfdB for catalyzing the chlorophenol compound. Of the selected substrates, both TfdB had the highest activity towards 2,4-dichlorophenol, while CTX3-TfdB had higher activity towards 2,3, 5-trichlorophenol, 2, 5-dichlorophenol, 3, 5-trichlorophenol, 3,4, 5-tetrachlorophenol. MIX-TfdB has high activity on 2, 3-dichlorophenol, 2, 5-dichlorophenol, 3, 4-dichlorophenol, 3, 5-trichlorophenol and 3,4, 5-tetrachlorophenol. The addition of FAD at a concentration of 0.005mM can effectively increase the reaction rate of TfdB. However, CTX3-TfdB and MIX-TfdB do not react to the addition of FAD to the same extent. For example, the addition of 0.005mM FAD increases CTX3-TfdB to about 30% of 3, 4-dichlorophenol activity. However, the addition of 0.005mM FAD did not significantly increase MIX-TfdB to 3, 4-dichlorophenol activity. It can be seen that the promotion of the two enzymes by FAD is not the same when the substrates are identical. In general, both enzymes have some activity on the chlorophenol substrate tested. Therefore, tfdB is a very novel and potentially an enzyme, which is beneficial in being able to convert more aromatics afterwards.
4. TfdB enzyme to CPs removal rate
The removal rate of CPs should be confirmed by high performance liquid chromatography, and also by measuring the UV-detected NADPH consumption. The present study indirectly reflects the removal rate of CPs by detecting the decrease in NADPH using an ultra-micro spectrophotometer. The results indicate that high enzymatic activity of CPs generally results in correspondingly high removal rates of CPs. As shown in fig. 13 a. CTX3-TfdB has higher enzyme activity on 2,4-DCP, 2,5-DCP and 2,3,5-TCP, and has higher removal rate. However, 3,5-DCP and 2,3,4-TCP have high removal rates but their enzymatic activities are not high. As shown in FIG. 13b, MIX-TfdB has higher enzyme activity on 2,4-DCP, 2,5-DCP, 3,4,5-TCP and higher removal rate. However, 3,4-DCP and 2,3,4-TCP have high removal rates but their enzymatic activities are not high. The results indicate that the high enzymatic activity of CPs generally results in correspondingly high removal rates of CPs, but with exceptions, may have a certain relationship with the structure of the CPs.
Depending on the nature of the enzyme, the reaction catalyzed by a particular hydroxylase requires FAD as a cofactor to stimulate its substrate. TfdB has high sequence and structural similarity with FAD-dependent hydroxylase and contains FAD as a prosthetic group. TfdB catalyzes FAD-dependent oxidative hydroxylation of 2,4-DCP and its homologs. The requirement of FAD for hydroxylase activity and removal of 19 CP homologs was studied to determine if FAD is a necessary cofactor for the enzyme. The results indicate that 0.005mMb FAD has different degrees of promotion for different CPs.
Claims (8)
1. The 2,4-dichlorophenol hydroxylase gene MIX-tfdB is characterized in that the nucleotide sequence is shown in SEQ ID NO. 5.
2. A MIX-TfdB protein is characterized in that the amino acid sequence is shown in SEQ ID NO. 6.
3. A2, 4-dichlorophenol hydroxylase gene CTX3-tfdB is characterized in that the nucleotide sequence is shown as SEQ ID NO. 3.
4. A CTX3-TfdB protein is characterized in that the amino acid sequence is shown in SEQ ID NO. 4.
5. Use of the gene MIX-tfdB according to claim 1 or the gene CTX3-tfdB according to claim 3 for degrading Chlorophenols (CPs).
6. Use of MIX-TfdB protein according to claim 2 or CTX3-TfdB protein according to claim 4 for degrading Chlorophenols (CPs).
7. Use of the gene MIX-tfdB according to claim 1 or the CTX3-tfdB according to claim 3 for the preparation of recombinant proteins and/or engineering bacteria for degrading chlorophenols.
8. The use according to claim 7, wherein the chlorophenol compound is selected from one or more of 2,4-DCP, 2,5-DCP, 3,4,5-TCP, 3,4-DCP, 2,3,4-TCP, 2,4,5-TCP, 2,3, 5-TCP.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211009302.6A CN116426547B (en) | 2022-08-22 | 2022-08-22 | Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211009302.6A CN116426547B (en) | 2022-08-22 | 2022-08-22 | Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116426547A true CN116426547A (en) | 2023-07-14 |
CN116426547B CN116426547B (en) | 2023-10-03 |
Family
ID=87078390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211009302.6A Active CN116426547B (en) | 2022-08-22 | 2022-08-22 | Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116426547B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1636065A (en) * | 2000-10-30 | 2005-07-06 | 拜尔农科股份有限公司 | Herbicide-tolerant plants through bypassing metabolic pathway |
US20190024109A1 (en) * | 2017-07-24 | 2019-01-24 | Spogen Biotech Inc. | Herbicide-detoxifying enzymes and uses thereof |
CN109699499A (en) * | 2018-08-27 | 2019-05-03 | 吉林大学 | A kind of transgenic arabidopsis for repairing PCBs contaminated soil |
-
2022
- 2022-08-22 CN CN202211009302.6A patent/CN116426547B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1636065A (en) * | 2000-10-30 | 2005-07-06 | 拜尔农科股份有限公司 | Herbicide-tolerant plants through bypassing metabolic pathway |
US20190024109A1 (en) * | 2017-07-24 | 2019-01-24 | Spogen Biotech Inc. | Herbicide-detoxifying enzymes and uses thereof |
CN109699499A (en) * | 2018-08-27 | 2019-05-03 | 吉林大学 | A kind of transgenic arabidopsis for repairing PCBs contaminated soil |
Non-Patent Citations (5)
Title |
---|
NGUYEN L HUONG ET AL.: "Chlorophenol hydroxylase activity encoded by TfdB from 2, 4-dichlorophenoxyacetic acid (2, 4-D)-degrading Bradyrhizobium sp. strain RD5-C2", 《BIOSCI BIOTECHNOL BIOCHEM.》, vol. 71, no. 7, pages 1691 - 1696 * |
Y. LU ET AL.: "Cloning and characterisation of a novel 2, 4-dichlorophenol hydroxylase from a metagenomic library derived from polychlorinated biphenyl-contaminated soil", 《BIOTECHNOL LETT》, no. 33, pages 1159 * |
YU, Y.: "2, 4-dichlorophenol 6-monooxygenase [Acinetobacter genomosp. 33YU]", 《GENBANK: ONN51478.1》, pages 1 - 2 * |
安松: "2, 4-二氯苯酚羟化酶的半理性设计改造及其催化机理研究", 《中国优秀硕士学位论文全文数据库工程科技I辑》, no. 08, pages 016 - 294 * |
路杨: "土壤宏基因组文库筛选除草剂降解基因", 《中国优秀博士学位论文全文数据库农业科技辑》, no. 09, pages 045 - 2 * |
Also Published As
Publication number | Publication date |
---|---|
CN116426547B (en) | 2023-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wunsch et al. | Functional domains of NosR, a novel transmembrane iron-sulfur flavoprotein necessary for nitrous oxide respiration | |
Maillard et al. | Characterization of the corrinoid iron-sulfur protein tetrachloroethene reductive dehalogenase of Dehalobacter restrictus | |
Lloyd et al. | Biochemical and genetic characterization of PpcA, a periplasmic c-type cytochrome in Geobacter sulfurreducens | |
Zacharoff et al. | Geobacter sulfurreducens extracellular multiheme cytochrome PgcA facilitates respiration to Fe (III) oxides but not electrodes | |
Dubbels et al. | Evidence for a copper-dependent iron transport system in the marine, magnetotactic bacterium strain MV-1 | |
Shapleigh et al. | Cloning, sequencing and deletion from the chromosome of the gene encoding subunit I of the aa3‐type cytochrome c oxidase of Rhodobacter sphaeroides | |
Huang et al. | Arsenic methylation by a novel ArsM As (III) S‐adenosylmethionine methyltransferase that requires only two conserved cysteine residues | |
CN113528477A (en) | Aflatoxin B capable of degrading1Construction method and application of manganese peroxidase mutant | |
Jeffrey et al. | Detection of the merA gene and its expression in the environment | |
Chen et al. | Conserved cysteine residues determine substrate specificity in a novel A s (III) S‐adenosylmethionine methyltransferase from A spergillus fumigatus | |
CN107603991A (en) | A kind of Catechol 2,3 dioxygenase genes and its application | |
Robin et al. | A sulfite respiration pathway from Thermus thermophilus and the key role of newly identified cytochrome c 550 | |
Li et al. | A type VI secretion system facilitates fitness, homeostasis, and competitive advantages for environmental adaptability and efficient nicotine biodegradation | |
CN116426547B (en) | Artificial transformation 2,4-dichlorophenol hydroxylase gene and application thereof | |
WO2014203046A1 (en) | The removal of arsenic using a dissimilatory arsenic reductase | |
Tang et al. | Role of the AcsF protein in Chloroflexus aurantiacus | |
CN114605557B (en) | Degradation aflatoxin B 1 And/or zearalenone fusion protein and preparation method and application thereof | |
Kabiri et al. | Effects of selenite and tellurite on growth, physiology, and proteome of a moderately halophilic bacterium | |
EP0871750B1 (en) | Removal of metals from contaminated substrates by plants | |
US10036072B2 (en) | Mercury methylation genes in bacteria and archaea | |
CN117384873A (en) | Glycerol phosphate oxidase mutant and screening method, preparation method and application thereof | |
CN104342409B (en) | Recombinate the preparation method of ginseng superoxide dismutase | |
Jin et al. | Sulfurospirillum diekertiae sp. nov., a tetrachloroethene-respiring bacterium isolated from contaminated soil | |
Do et al. | Biochemical and structural basis of mercuric reductase, GbsMerA, from Gelidibacter salicanalis PAMC21136 | |
Kronen et al. | Evidence for a putative isoprene reductase in Acetobacterium wieringae |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |